Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US GAO report reveals increasing hardship for seniors with expensive drugs

This article was originally published in Scrip

Executive Summary

A key House Democratic leader, Representative Pete Stark, has pointed to a March 1st report from the Government Accountability Office (GAO), the investigative arm of Congress, which shows that seniors' out-of-pocket costs for "specialty-tier" prescription drugs are escalating rapidly and causing great hardship. These products, which tend to be the most expensive drugs available for Medicare patients and are affected by the "doughnut hole" coverage gap, include cancer drugs.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC007132

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel